Skip to main content
. 2015 Aug 17;64(12):4226–4237. doi: 10.2337/db15-0521

Figure 8.

Figure 8

miR-92a overexpression downregulates inflammation and myeloid differentiation CD34+ cells obtained from patients with diabetes. A: miR-92a mimic (5 nmol/L) was overexpressed in CD34+ cells using Optimem and Lipofectamine 2000, and the miR-92a expression was evaluated using qRT-CPR. Bar chart showing upregulation in expression of miR-92a after treatment with miR-92a mimic. B: miR-92a mimic treatment showing downregulation in IL-1β mRNA expression. C: Bar chart showing surface expression of CD14 after treatment with miR-92a mimic determined using flow cytometry. n = 4.